Q: What is Adaptive Biotechnologies Corporation Common Stock's WACC?

Adaptive Biotechnologies Corporation Common Stock (ADPT) has a Weighted Average Cost of Capital (WACC) of 12.45%. This is calculated using a Cost of Equity of 12.69% (via CAPM with a beta of 2.00) and a pre-tax Cost of Debt of 8.69%, with an equity weight of 93.90% in the capital structure.

Q: Is Adaptive Biotechnologies Corporation Common Stock's WACC high or low?

Adaptive Biotechnologies Corporation Common Stock's WACC of 12.45% is above the typical range, indicating higher perceived risk and cost of capital. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Q: How is Adaptive Biotechnologies Corporation Common Stock's WACC calculated?

Adaptive Biotechnologies Corporation Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 12.69% is derived from the CAPM model using a beta of 2.00. The pre-tax Cost of Debt (Rd) is 8.69%. The capital structure is 93.90% equity and 6.10% debt.

Question 1

What is Adaptive Biotechnologies Corporation Common Stock's WACC?

Accepted Answer

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）当前估算的 WACC 为 12.45%。其中股权成本为 12.69%，税前债务成本为 8.69%，股权权重为 93.90%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较高区间，通常意味着资本成本更高、估值对折现率更敏感。

Question 2

Is Adaptive Biotechnologies Corporation Common Stock's WACC high or low?

Accepted Answer

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）当前估算的 WACC 为 12.45%。其中股权成本为 12.69%，税前债务成本为 8.69%，股权权重为 93.90%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较高区间，通常意味着资本成本更高、估值对折现率更敏感。

Question 3

How is Adaptive Biotechnologies Corporation Common Stock's WACC calculated?

Accepted Answer

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）当前估算的 WACC 为 12.45%。其中股权成本为 12.69%，税前债务成本为 8.69%，股权权重为 93.90%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较高区间，通常意味着资本成本更高、估值对折现率更敏感。

Adaptive Biotechnologies Corporation Common Stock (ADPT) — WACC 分析

WACC 构成

解读

Adaptive Biotechnologies Corporation Common Stock（ADPT）WACC：12.45%

WACC计算器

Adaptive Biotechnologies Corporation Common Stock（ADPT） WACC 解读

ADPT 公司分析

ADPT DCF 估值

继续做同行对比